In Mexico, the FLT3 mutational profile is not routinely performed in most public institutions; therefore, little epidemiological data exist about prevalence and heterogeneity of FLT3 mutations and their influence on clinical evolution in both AML adult and pediatric patients. The gene discussed is FLT3; the disease is acute myeloid leukemia.